- Naranj Research Desk
- 🇸🇦 Saudi Stock Market
- 🇺🇸 USA Stock Market
4% – 5%
12 - 14 Days
4% – 5%
12 - 14 Days
JAMJOOM PHARMA — TASI —
| EMA | Value | Stock Position |
|---|---|---|
| 5 EMA | 56.88 | Above |
| 10 EMA | 55.2 | Above |
| 20 EMA | 52.42 | Above |
| 50 EMA | 47.51 | Above |
| 100 EMA | 45.6 | Above |
| 200 EMA | 47.56 | Above |
| Indicator | Value | Zone |
|---|---|---|
| RSI-14 | 63.20 | Neutral |
| CCI-20 | 56.50 | Neutral |
| Stochastic RSI | 32.90 | Neutral |
| Stochastic %K | 47.50 | Neutral |
| William %R | -16.20 | Neutral |
Based on our short term trading advice for Saudi Tadawul, Jamjoom Pharmaceuticals Factory stock price target will be SAR 162 - SAR 164 in the next 12-14 trading sessions.
Arijit Banerjee CMT CFTe is a seasoned expert in the financial industry, boasting decades of experience in trading, investment, and wealth management. As the founder and chief strategist of Naranj Capital, he’s built a reputation for providing insightful research analysis to guide investment decisions.
Arijit’s credentials are impressive, holding both the Chartered Market Technician (CMT) and Certified Financial Technician (CFTe) designations. These certifications demonstrate his expertise in technical analysis and financial markets.
Through Naranj Capital, Arijit shares his market insights and research analysis, offering actionable advice for investors. His work is featured on platforms like TradingView, where he publishes detailed analysis and recommendations.
If you’re interested in learning more about Arijit’s work or Naranj Capital’s services, you can reach out to them directly through their website
